Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00051259 · ClinicalTrials.gov registry record · Phase 3
Effects of Antidepressants on Sexual Functioning
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 420
- Enrollment target
NCT00051259: Completed Phase 3 study, sponsored by GlaxoSmithKline.
NCT00051259 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 420 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (46% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00051259, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 420 participants
- Enrollment target
Study Summary
The purpose of this trial is to study the effects of two depression medications on sexual functioning.
Interventions
- DRUG Extended-Release Bupropion Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2003-01 |
| Est. Completion | 2004-06 |
| Phase | Phase 3 |
What the finished NCT00051259 record still lists
NCT00051259 is an interventional study that assigns participants to a tested intervention. The registered 420 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (46% lower).
The record links to 0 conditions, and to 1 intervention - of which Extended-Release Bupropion Hydrochloride is the first listed.
NCT00051259 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00051259 about?
NCT00051259 is a clinical study titled "Effects of Antidepressants on Sexual Functioning". The purpose of this trial is to study the effects of two depression medications on sexual functioning.
What is the current status of trial NCT00051259?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 420 participants. The study started on 2003-01. Estimated completion is 2004-06.
What interventions are being tested in trial NCT00051259?
The interventions under investigation include: Extended-Release Bupropion Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00051259?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00051259's enrollment target sits among peer trials
420 891st of 2000 higher than 1,102 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
- NCT04149743 · 420 participants · NA
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia